Takeda Pharmaceutical Company Limited Equity And Liabilities
Takeda Pharmaceutical Company Limited (TAK) had Equity And Liabilities of JPY 14.25 trillion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:EquityAndLiabilities · last filed 2025-06-25
- 2025-03-31: Equity And Liabilities 14.25T JPY.
- 2024-03-31: Equity And Liabilities 15.11T JPY.
- 2023-03-31: Equity And Liabilities 13.96T JPY.
- 2022-03-31: Equity And Liabilities 13.18T JPY.
| Period end | Equity And Liabilities | Equity And Liabilities as first filed |
|---|---|---|
| 2025-03-31 | 14.25T JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 15.11T JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 13.96T JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 13.18T JPY 20-F · filed 2023-06-28 | |
| 2021-03-31 | 12.91T JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 12.82T JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 13.79T JPY 20-F · filed 2020-06-24 | 13.87T JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 4.11T JPY 20-F · filed 2019-06-27 |